NIH-funded research R01 grant

Understanding diagnostic errors in U.S. emergency care and their impact on patients and costs

Official title: The Epidemiology of Diagnostic Error in Emergency Care in the United States and the Association with Patient Outcomes and Healthcare Costs

Funded at Beth Israel Deaconess Medical Center · NIH-10932292 · Data updated 2026-11-12

This study looks at how often mistakes happen when diagnosing patients in emergency rooms and what those mistakes mean for people's health, so we can find ways to make sure everyone gets the right care when they need it most.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 30, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$496,131
NIH project number5R01HS029781-02
Project IDNIH-10932292 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced emergency care in U.S. emergency departments and may have been affected by diagnostic errors.

Less likely to help

Patients who have not utilized emergency services or those with conditions that do not typically present in emergency settings may not benefit from this research.

What this research studies

This research investigates the prevalence and consequences of diagnostic errors in emergency departments across the United States. By analyzing national claims data, the study aims to quantify how often these errors occur, particularly for high-risk conditions, and to identify the symptoms commonly associated with them. The research will also explore the relationship between diagnostic errors and patient outcomes, as well as the factors that contribute to these errors in emergency care settings. This information is crucial for improving diagnostic accuracy and patient safety in emergency medicine.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic practices in emergency care, ultimately enhancing patient safety and reducing healthcare costs.

How similar studies have gone: Previous research has indicated that addressing diagnostic errors in emergency care can lead to significant improvements in patient outcomes, suggesting that this approach has potential for success.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Burke, Laura G — Beth Israel Deaconess Medical Center
  • Study coordinator: Burke, Laura G

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.